My-Luong Vuong

2PUBLICATIONS
16CO-AUTHORS
Epidemiological modellingMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.

My-Luong Vuong, Omar Elkayal, Ruth Van Daele

|May 29, 2025
A Multiple Imputation Workflow for Handling Missing Covariate Data in Pharmacometrics Modeling.

My-Luong Vuong, Geert Verbeke, Erwin Dreesen

Pageof 1

Frequent Collaborators

2 joint publications

Erwin Dreesen

1 joint publications

Geert Verbeke

1 joint publications

Omar Elkayal

1 joint publications

Ruth Van Daele

1 joint publications

Jan-Willem C Alffenaar

1 joint publications

Sophie L Stocker

1 joint publications

Jason A Roberts

1 joint publications

Yves Debaveye

1 joint publications

Joost Wauters

1 joint publications

Beatrijs Mertens

Frequent Collaborators

2 joint publications

Erwin Dreesen

1 joint publications

Geert Verbeke

1 joint publications

Omar Elkayal

1 joint publications

Ruth Van Daele

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.7K
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on : Jan 08, 2020

14.7K
See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.7K
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on : Jan 08, 2020

14.7K
See more related videos